A consortium of European researchers and technology companies recently completed the EU-funded SAVE project, aimed at simplifying the execution data-intensive applications on complex hardware architectures.
Argonne National Laboratory is partnering with the University of Chicago and the City of Chicago to launch an open access urban sensing project - the Array of Things - to better understand and improve the cities.
UK scientists from the British Geological Survey (BGS) and the University of Edinburgh set off this week to the earthquake affected area of central Italy. The researchers will deploy seismometers to help better understand the science of aftershocks and how scientists might better assist global emergency response.
The Earlham Institute (EI) is adding a state-of-the-art DNA Foundry for synthetic biology to its advanced suite of sequencing technologies.
LIMS provider LabVantage has extended its partnership with Lonza to offer purpose-built environmental monitoring capabilities integrated with its software.
IBM scientists have developed a new lab-on-a-chip technology that can, for the first time, separate biological particles at the nanoscale
Biologists and mathematicians from the Moscow Institute of Physics and Technology have accelerated the rate at which a computer can predict the structure of protein complexes in a cell
Researchers from the University of the Basque Country (UPV/EHU) have created a bioinformatics tool, WREGEX 2.0, to predict the effect of cancer-related mutations. Created by a multidisciplinary team the software can analyse up to 40,000 proteins per minute
Certara, a specialist in simulation-enabled drug development, has announced that the US Food and Drug Administrations (FDA) Center for Veterinary Medicine has extended a five year research agreement until 2020.
Robert Roe discovers that data integrity, process improvement, and managing data effectively are key challenges for informatics providers finding the speed to innovate, as the theme for the latest Paperless Lab Academy suggested
Drug development is facing change – both from technological pressures, such as the use of AI and machine learning, plus new regulations which are driving sweeping changes to the way electronic records are created and stored for clinical trials.
Robert Roe speaks with laboratory informatics software providers about the future of their software and the introduction of new technologies, such as AI and deep learning
Scientists are now beginning to use new technologies such as the internet of things (IoT), artificial intelligence (AI) and machine learning (ML) in their daily workflows.
In today’s world, where drug development integrates science and technology, consumer safety is paramount in the pharmaceutical industry.
